Patents Represented by Attorney, Agent or Law Firm Christine C. O'Day
  • Patent number: 6627274
    Abstract: A multilayer heat shrinkable film having high heat shrink, high burn-through resistance and a broad impulse sealing range including an outer and a heat sealable inner layer each of a thermoplastic polymer or copolymer, wherein said outer layer has a melting point at least 20° C. higher than said inner layer.
    Type: Grant
    Filed: October 1, 2001
    Date of Patent: September 30, 2003
    Assignee: Sporos SA
    Inventors: Stamatis Ginossatis, Jens Hestbech
  • Patent number: 6627308
    Abstract: The present invention relates to a release film comprising: a polyester film; a coating layer formed on one surface of said polyester film; and a release layer formed on a surface of said coating layer which exhibits a residual adhesion rate of not less than 80%, said release film satisfying all of the conditions represented by the following formulae (1) to (3): OL≦0.6 (1) TL≧80 (2) TL(H)≦8 (3)  wherein OL is an amount (mg/m2) of oligomers extracted with dimethylformamide from a surface of said release layer after the release film is heat-treated at a temperature of 180° C. for 10 minutes; TL is a total light transmittance (%) of said release film; and TL(H) is a total light transmittance (%) of a laminate prepared by interposing said release film between two polarizing plates disposed in a perpendicular relation to each other.
    Type: Grant
    Filed: April 3, 2001
    Date of Patent: September 30, 2003
    Assignee: Mitsubishi Polyester Films Corporation
    Inventors: Kimihiro Isaki, Masashi Inagaki
  • Patent number: 6623863
    Abstract: There are provided articles coated with high-performance water-repellent films with high hardness that can withstand outdoor use, which are water-repellent film-coated articles that comprise a substrate and a water-repellent film composed mainly of silicon oxide and having a water-repellent group coated on the surface of the substrate, and are characterized by containing at least one type of metal oxide selected from the group consisting of magnesium oxide, calcium oxide, strontium oxide and boron oxide, as well as a process for preparation of such water-repellent film-coated articles at a high rate of productivity and a coating liquid composition for preparation of such water-repellent film-coated articles.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: September 23, 2003
    Assignee: Nippon Sheet Glass Co., Ltd.
    Inventors: Kazutaka Kamitani, Hiroaki Yamamoto
  • Patent number: 6613761
    Abstract: This invention provides new benzoxazepine compounds represented by the formula: [wherein R stands for a lower alkyl group optionally substituted with a hydroxyl group, X stands for an optionally substituted carbamoyl group or an optionally substituted heterocyclic group having a deprotonatable hydrogen atom, R1 stands for a lower alkyl group and W stands for a halogen atom] having activities of lowering cholesterol-level and lowering trigluceride-level, and being useful for prophylaxis and therapy of hyperlipidemia.
    Type: Grant
    Filed: June 6, 2000
    Date of Patent: September 2, 2003
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Hidefumi Yukimasa, Yasuo Sugiyama, Ryuichi Tozawa
  • Patent number: 6611375
    Abstract: A novel, cost effective optical filter is employed for photosensors used in ultraviolet-based water purification systems. Optically tuned to specifically eliminate the non-germicidal wavelength polychromatic emissions from mercury lamps, this unique optical filter approach significantly reduces the cost in manufacturing reliable water purification systems employing ultraviolet light.
    Type: Grant
    Filed: December 13, 2002
    Date of Patent: August 26, 2003
    Assignee: Thermo Corion Corporation
    Inventor: Jamie Knapp
  • Patent number: 6608214
    Abstract: This invention provides a novel process for producing optically active 3-hydroxy-&ggr;-butyrolactone in a short step, which is superior economically and in efficiency and industrially suitable by using a starting material which is inexpensive and easily available and reagents easy to handle. This invention relates to a process for producing optically active 3-hydroxy-&ggr;-butyrolactone represented by formula I: wherein the symbol * means an asymmetric carbon atom, which comprises hydrogenating an optically active 4-substituted oxy-3-hydroxybutyrate represented by formula II: wherein R1 represents a C1-4 lower alkyl group, R2 represents a protective group for a hydroxyl group deprotected by hydrogenation with a heterogeneous hydrogenation catalyst, and the symbol * has the same meaning as defined above, in the presence of a heterogeneous hydrogenation catalyst and an acidic substance followed by deprotection and simultaneous ring closure thereof.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: August 19, 2003
    Assignee: Takasago International Corporation
    Inventors: Tsukasa Sotoguchi, Takaji Matsumoto, Motonobu Takenaka, Takashi Miura
  • Patent number: 6603046
    Abstract: The invention is drawn to novel bis-aromatic a,&bgr;-unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria.
    Type: Grant
    Filed: May 27, 1998
    Date of Patent: August 5, 2003
    Assignee: Lica Pharmaceuticals A/S
    Inventors: Arsalan Kharazmi, Søren Brøgger Christensen, Chen Ming, Thor Grundtvig Theander
  • Patent number: 6603057
    Abstract: Functions of sno gene are analyzed by constructing heterogenous or homogeneous mouse variants lacking sno gene to thereby provide heterogenous or homogeneous mouse variants lacking sno gene, cells of these animals and screening systems with the use of these animals or cells. Non-human animals, preferably mice, lacking sno gene and cells thereof. The above animals or cells thereof include both of heterogenous variants and homogeneous variants. A method for screening candidates for drugs by using the above animals or cells thereof.
    Type: Grant
    Filed: September 11, 2001
    Date of Patent: August 5, 2003
    Assignees: Japan Science and Technology Corporation, Riken
    Inventor: Shunsuke Ishii
  • Patent number: 6599529
    Abstract: An oral pharmaceutical modified release multiple-units composition for the administration of a therapeutically and/or prophylactically effective amount of a non-steroid anti-inflammatory drug substance to obtain both a relatively fast onset of the therapeutic effect and the maintenance of a therapeutically active plasma concentration for a relatively long period of time is disclosed.
    Type: Grant
    Filed: July 17, 2000
    Date of Patent: July 29, 2003
    Assignee: Nycomed Danmark A/S
    Inventors: Annette Skinhøj, Poul Bertelsen
  • Patent number: 6587264
    Abstract: A novel, cost effective optical filter is employed for photosensors used in ultraviolet-based water purification systems. Optically tuned to specifically eliminate the non-germicidal wavelength polychromatic emissions from mercury lamps, this unique optical filter approach significantly reduces the cost in manufacturing reliable water purification systems employing ultraviolet light.
    Type: Grant
    Filed: January 18, 2001
    Date of Patent: July 1, 2003
    Assignee: Thermo Corion Corporation
    Inventor: Jamie Knapp
  • Patent number: 6576811
    Abstract: The present invention provides a human c-Ha-ras proto-oncogene transgenic rat and the methods of the screening of many carcinogens and the screenings of promoters of carcinogenesis and preventive and inhibitory agents of tumors, and additionally enables the analysis of the carcinogenesis mechanism of a number of tumors.
    Type: Grant
    Filed: August 26, 1998
    Date of Patent: June 10, 2003
    Assignees: National Cancer Center Research Institute, Japan Science and Technology Corporation
    Inventors: Hiroyuki Tsuda, Makoto Asamoto, Hiroyasu Toriyama, Takahiro Ochiya, Takeo Sekiya
  • Patent number: 6569862
    Abstract: The present invention relates to methods for modulating calcium sensitivity of cardiac muscle. In preferred aspects, the invention provides methods for enhancing myocardial contractility and cardiac performance, and methods for treatment of heart failure and other disorders associated with cardiac contractility by administration of one or more xanthine oxidase inhibitor compounds.
    Type: Grant
    Filed: October 6, 2000
    Date of Patent: May 27, 2003
    Assignee: Johns Hopkins University
    Inventor: Eduardo Marban
  • Patent number: 6566336
    Abstract: The invention provides a compound recognizing the minor group of hydrogen bonds between base pairs and being capable of forming a covalent bond with bases. The inventive compound can recognize a specific nucleotide sequence and can strongly bind to adjacent bases via covalent bonding, to regulate the expression of a DNA with the nucleotide sequence. The invention provides a DNA alkylating agent comprising a compound represented by the general formula I: wherein R represents a lower amyl group or a polyamide group; and X represents nitrogen or CH.
    Type: Grant
    Filed: May 30, 2000
    Date of Patent: May 20, 2003
    Assignee: Japan Science and Technology Corporation
    Inventors: Hiroshi Sugiyama, Zhi Fu Tao, Isao Saito
  • Patent number: 6564836
    Abstract: The present invention provides an apparatus that lifts, secures, splits and/or crushes tree stumps or other materials, particularly wooden materials and other materials that may be present at an excavation site. The apparatus is characterized in part by a two pivot point design. A first pivot point allows for the pivotable operation of an engaging unit which grabs and lifts the tree stump. The engaging unit further acts a durable and secure support member for the tree stump during the splitting and crushing process. The second pivot point allows for the pivotable operation of a cutting device which facilitates splitting and crushing of the stumps.
    Type: Grant
    Filed: August 14, 2001
    Date of Patent: May 20, 2003
    Inventor: Douglas Cook
  • Patent number: 6559320
    Abstract: The present invention relates to a novel process for preparing pyrrole ester compounds, which are key intermediates in the preparation of farnesyl transferase inhibitors, an anti-cancer agent Horner-Emmons reaction of aldehyde compounds provides the corresponding &agr;,&bgr;-unsaturated esters, which without any separation and/or purification steps, are treated with toluenesutfonyl-methylisocyanate in the presence of base to give pyrrole esters in one-pot fashion.
    Type: Grant
    Filed: August 22, 2002
    Date of Patent: May 6, 2003
    Assignee: LG Chem Investment Ltd.
    Inventors: Hyun Ik Shin, Sung Tak Oh, Jay Hyok Chang, Kyoo Woong Lee
  • Patent number: 6545132
    Abstract: A microsphere is prepared containing a compound possessing physiological activity coupled to a styrene-glycidyl methacrylate polymer through a spacer. Compounds that may be used include receptors such as proteins, and 3-[(5-(2,3-dimethoxy-6-methyl-benzoquinonyl)]-2-nonyl-2-propionic acid. A preferred spacer is an ethylene glycol diglycidyl ether derivative. Preferably, the whole surface of the styrene-glycidyl methacrylate polymer is covered with glycidyl methacrylate. The microsphere may be used for isolating and detecting substances such as proteins that bind to the coupled compound.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: April 8, 2003
    Inventors: Hiroshi Handa, Haruma Kawaguchi
  • Patent number: 6522272
    Abstract: An analogue frontend, such as is used, for example, in receivers for communications equipment, comprises a plurality of analogue components (1-3) which are connected upstream of an analogue/digital converter (4). In order to control the drive level of the individual analogue components (1-3) precisely, the input of the analogue/digital converter (4) can optionally be connected via a switch-over device (8) to the output of any one of the analogue components (1-3) and a drive level control signal for the respective analogue component (1-3) can be generated by a digital control device (5) by evaluating the sampled value which is then supplied by the analogue/digital converter (4).
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: February 18, 2003
    Assignee: Infineon Technologies, AG
    Inventors: Andreas Menkhoff, Peter Schöllhorn
  • Patent number: 6515528
    Abstract: A flip-flop circuit comprises a master latch circuit (2), which receives an input signal (D), and, connected in series therewith, a slave latch circuit (3), the two latch circuits (2, 3) being actuated complementarily-to one another by a clock signal. The output signal value (Q,{overscore (Q)}) of the flip-flop circuit is emitted from the output of the slave latch circuit (3) not directly but via a non-differential output driver circuit (4), e.g. an inverter circuit.
    Type: Grant
    Filed: March 20, 2002
    Date of Patent: February 4, 2003
    Assignee: Infineon Technologies AG
    Inventor: Ulf Tohsche
  • Patent number: D472241
    Type: Grant
    Filed: February 4, 2002
    Date of Patent: March 25, 2003
    Assignee: Andamiro Co., Ltd.
    Inventor: Yong Hwan Kim
  • Patent number: D472279
    Type: Grant
    Filed: February 4, 2002
    Date of Patent: March 25, 2003
    Assignee: Andamiro Co., Ltd.
    Inventor: Yong Hwan Kim